Month: October 2019

A Biogen Idec lab technician Suzanne Kreiter | The Boston Globe | Getty Images Biotechnology stocks are emerging as the standout performers in October. The Biotech ETF (IBB) is up 8% in October, while the S&P 500 is up about 2% in the same month. The IBB is on pace for its best month since
0 Comments
Apple CEO Tim Cook Spencer Platt | Getty Images Apple on Wednesday evening reported stronger-than-expected earnings for the fourth quarter and analysts mostly put out glowing reviews. Yet the stock is barely higher Thursday morning. That’s because of a report on Thursday revealed China is doubtful about reaching a comprehensive long-term trade deal with the
0 Comments
Former Massachusetts Governor and Republican presidential candidate Mitt Romney is interviewed at the Silicon Slopes Tech Conference on January 19, 2018 in Salt Lake City, Utah. George Frey | Getty Images Sen. Mitt Romney, R-Utah, is taking the lead on a new proposal aimed at fixing funding shortfalls for Social Security, Medicare and the nation’s
0 Comments
A regenerative medicine company in Vancouver, British Columbia that focuses on treatments for nerve damage and neurodegenerative diseases announced it will begin Phase 1 studies in early 2020 on a new treatment for Alzheimer’s disease. NervGen Pharma wants to advance its proprietary therapeutic technology platform, currently in development for spinal cord injury and multiple sclerosis
0 Comments
We are entering the giving season when the majority of charitable donations are made. Most affluent individuals make charitable donations, but the vast majority continue to simply pay cash. That’s the most expensive and inefficient possible method to benefit their charitable causes. It’s easy to write a check or pull out your credit card, but
0 Comments